Mutations inhibiting KDM4B drive ALT activation in ATRX-mutated glioblastomas

Alternative Lengthening of Telomeres (ALT) is a telomere maintenance pathway utilised in 15% of cancers. ALT cancers are strongly associated with inactivating mutations in ATRX; yet loss of ATRX alone is insufficient to trigger ALT, suggesting that additional cooperating factors are involved. We ide...

Descripción completa

Detalles Bibliográficos
Autores principales: Udugama, M., Hii, L., Garvie, A., Cervini, M., Vinod, B., Chan, F.-L., Das, P. P., Mann, J. R., Collas, P., Voon, H. P. J., Wong, L. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110556/
https://www.ncbi.nlm.nih.gov/pubmed/33972520
http://dx.doi.org/10.1038/s41467-021-22543-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110556/
https://www.ncbi.nlm.nih.gov/pubmed/33972520
http://dx.doi.org/10.1038/s41467-021-22543-z

Ejemplares similares